Showing results (2171-2180 of 3,833) with videos related to

Sort By:
Pageof 384
The Japanese Journal of Antibiotics|April 30, 1999
[Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics]M Takenaka, Y Morikawa, T Nakagawa, et al.
The Japanese Journal of Antibiotics|February 5, 2000
[In vitro antibacterial activities of carbapenems against clinical isolates]M Murase
The Japanese Journal of Antibiotics|June 2, 2000
[Proposed mechanism of action of metalloendopeptidase-F in the treatment of patients with chronic hepatitis B or C infection]S Fujisaki, T Fujisaki, J Yoshida, et al.
The Japanese Journal of Antibiotics|June 2, 2000
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro]M Kouda, S Homma, I Udagawa, et al.
The Japanese Journal of Antibiotics|June 2, 2000
[In vitro activity of faropenem against beta-lactamase producing clinical isolates]T Nishiyama, K Matsuzaki, H Koyama, et al.
The Japanese Journal of Antibiotics|February 24, 2001
[In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC]M Inoue, A Kuga, S Kaieda, et al.
The Japanese Journal of Antibiotics|February 24, 2001
[Evaluation of antibiotic preparations for children from a standpoint of water-solubilities]Y Honda, M Nakano
The Japanese Journal of Antibiotics|June 1, 1975
Experimental studies on absorption, distribution and excretion of a new antibiotic, fosfomycin. II. Absorption of oral preparations of fosfomycin calcium salt in dogs (author's transl)M Fujita, N Tomo, M Abe, et al.
The Japanese Journal of Antibiotics|January 5, 2002
[Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections]M Hasui, Y Kobayashi, Y Harada, et al.
The Japanese Journal of Antibiotics|December 10, 1999
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]T Nasu, K Okamoto, T Nakanishi, et al.
Pageof 384